Zydus Lifesciences Secures FDA Approval for Apalutamide Tablets

💊

has received FDA approval to manufacture 60 mg Apalutamide tablets, used for treating metastatic castration-sensitive prostate cancer. The drug, with annual US sales of $1.1 billion, will be produced at the company's Ahmedabad facility.